• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

Access to Iplex for Patients with ALS

July 27, 2009

Insmed Inc, today announced that, effective immediately, the Company will cease the supply of Iplex to any new patients. In addition, the Company will not initiate further clinical trials with Iplex at this time. The Company has determined that its limited inventory on hand must be conserved for the treatment of existing patients.

Statement from Insmed